Cargando…
CXCR1/2 antagonism with CXCL8/Interleukin-8 analogue CXCL8((3–72))K11R/G31P restricts lung cancer growth by inhibiting tumor cell proliferation and suppressing angiogenesis
CXCR1 and CXCR2 together with cognate chemokines are significantly upregulated in a number of cancers, where they act as key regulators of tumor cell proliferation, metastasis, and angiogenesis. We have previously reported a mutant protein of CXCL8/Interleukin-8, CXCL8((3–72))K11R/G31P (G31P), which...
Autores principales: | Khan, Muhammad Noman, Wang, Bing, Wei, Jing, Zhang, Yingqiu, Li, Qiang, Luan, Xuelin, Cheng, Jya-Wei, Gordon, John R., Li, Fang, Liu, Han |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673267/ https://www.ncbi.nlm.nih.gov/pubmed/26087179 |
Ejemplares similares
-
Effects of K11R and G31P Mutations on the Structure and Biological Activities of CXCL8: Solution Structure of Human CXCL8((3-72))K11R/G31P
por: Cheng, Hsi-Tsung, et al.
Publicado: (2017) -
Differential Effects of Posttranslational Modifications of CXCL8/Interleukin-8 on CXCR1 and CXCR2 Internalization and Signaling Properties
por: Vacchini, Alessandro, et al.
Publicado: (2018) -
The CXCL8-CXCR1/2 pathways in cancer
por: Liu, Qian, et al.
Publicado: (2016) -
Peptides derived from CXCL8 based on in silico analysis inhibit CXCL8 interactions with its receptor CXCR1
por: Jiang, Shinn-Jong, et al.
Publicado: (2015) -
Porcine CXCR1/2 antagonist CXCL8((3–72))G31P inhibits lung inflammation in LPS-challenged mice
por: Wang, Xue, et al.
Publicado: (2020)